This is a firm fixed price purchase order awarded to Becton, Dickinson and Company (BD) by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) for maintenance support services. The contract, which does not have a set-aside designation, has a potential value of $110,986.32 and a period of performance ending on September 20, 2019. BD, a global medical technology company, has extensive experience providing equipment, reagents, and services to support...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Becton, Dickinson and Company (BD) to de-install and reinstall equipment. The contract has a ceiling value of $15,000.00 and an ultimate completion date of August 15, 2024. This award does not have a set-aside designation. BD is a global medical technology company that provides a wide range of products and services to federal agencies, including instruments, reagents, and supplies for...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Becton, Dickinson & Co. (BD), a global medical technology company, with a ceiling value of $93,377.04. The contract is for services, with a period of performance ending on September 20, 2022. BD, a for-profit manufacturer of medical devices and instruments, has a significant presence in federal contracting across healthcare and research domains, providing specialized...
This firm fixed-price definitive contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Becton, Dickinson and Company (BD) to provide lab equipment. The contract has a potential value of $580,564.38 and a completion date of September 20, 2019. BD is a global medical technology company that provides a wide range of goods and services, including laboratory equipment and diagnostic products, to U.S. government agencies through prime...
This $110,986.32 firm fixed-price purchase order contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Becton, Dickinson And Company (BD), a global medical technology company, to provide laboratory instruments. The contract does not have a set-aside designation. BD, through its BD Biosciences division, is a major supplier of products and services for laboratory and biomedical research applications, including flow cytometers, cell...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Becton, Dickinson and Company (BD), a manufacturer of medical devices and supplies. The contract has a ceiling value of $194,940.24 and an ultimate completion date of September 20, 2024. The contract is not set aside for any small business designation. BD is a major manufacturer and supplier of medical equipment and consumables, including needles, syringes, intravenous catheters,...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Becton, Dickinson and Company (BD) for annual repairs and maintenance of BD flow cytometers. The contract has a ceiling value of $17,834.96 and a period of performance through January 31, 2025. No set-aside designation was used. BD is a global medical technology company that provides specialized equipment, reagents, and services for biomedical research and clinical applications, including...
This is a $180,091.68 firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Becton, Dickinson and Company (BD) for a maintenance agreement on equipment. The contract has an ultimate completion date of September 20, 2021. It is not set aside for any specific business type. BD is a global medical technology company that provides a range of goods and services to U.S. government agencies, including the Department of Veterans Affairs, National...
This is a firm fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Becton, Dickinson and Company (BD) for $568,907.00. The contract is for FACSARIA FUSION WITH OPTION HOOD SAFETY BIOLOGICAL products and services. BD is a global medical technology company that supplies specialized equipment and consumables to support biomedical research and clinical programs for various federal agencies. The...
This is a firm fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Becton, Dickinson and Company (BD) for $107,265.00. The contract does not have a set-aside designation. BD is a global medical technology company that provides a range of goods and services to U.S. government agencies, including specialized biomedical equipment, reagents, and laboratory supplies to support research and clinical...